Intersect ENT (XENT) Misses Q2 EPS by 6c

Intersect ENT (NASDAQ: XENT) reported Q2 EPS of ($0.49), $0.06 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $27.3 million versus the consensus estimate of $28.02 million.

For earnings history and earnings-related data on Intersect ENT (XENT) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Baidu slips as Q2 results miss estimates despite growth in AI cloud business
• Eltek Ltd (ELTK) Reports Q2 EPS of $0.41